Concomitant use of proton-pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI

Granger, Christopher B.; Juurlink, D.
August 2009
ACP Journal Club;8/18/2009, Vol. 151 Issue 2, p11
Academic Journal
The article reports that in older patients discharged from hospital after acute myocardial infarction (MI), concomitant use of proton-pump inhibitors (PPI) is associated with increased risk for readmission for or death from MI within 90 days of initial discharge. In a study of 782 patients were readmitted for or died from MI within 90 days of initial discharge and the use of PPIs was associated with increased risk for readmission for or death from MI.


Related Articles

  • Conflicting Evidence: What's a Clinician to Do? de Aquino Lima, Joao Paulo; Brophy, James M. // Annals of Internal Medicine;9/21/2010, Vol. 153 Issue 6, p413 

    The authors discuss an article by M. Charlot to analyze the association between myocardial infarction, cardiovascular death, or stroke and the use of proton-pump inhibitors (PPI) in patients who have had a myocardial infarction, published within this issue. The authors suggest that to clinically...

  • Cardiovascular highlights from non-cardiology journals. O'Flaherty, Martin; Huffman, Mark D.; Capewell, Simon // Heart;Sep2015, Vol. 101 Issue 17, p1433 

    The article focuses on a study on decreasing mortality rates of acute myocardial infarction (AMI) and coronary heart disease (CHD). Topics discussed include a decrease in mortality rates shown by multinational monitoring of trends and determinants in cardiovascular disease (MONICA) project...

  • Always look on the bright side…. McCrory, P. // British Journal of Sports Medicine;Feb2007, Vol. 41 Issue 2, p63 

    The author reflects on the increasing number cardiovascular mortality in sports. According to the author, several studies have demonstrated increased cardiovascular mortality with the outcome of local and national football teams. He pointed that mostly is male mortality from myocardial...

  • DES show mortality benefit in AMI. Lindsay, Alistair C.; Qureshi, Katie // Heart;Jan2009, Vol. 95 Issue 1, p93 

    The article reports on the study about drug-eluting stents (DES), which shows mortality benefit in acute myocardial infarction (AMI). The study was based on an unselected, population based cohort of 7217 patients undergoing PCI with stenting for AMI over an 18-month period in Massachusetts...

  • PPIs and clopidogrel. Elliott, William T. // Clinical Cardiology Alert;May2009 Pharmacology Watch, p2 

    The article discusses research on proton pump inhibitors (PPIs) and clopidogrel in patients with acute coronary syndrome (ACS). It references a study published in a 2009 issue of the "Journal of the American Medical Association." According to the cohort study of 8,205 patients, PPIs affect the...

  • Is double-dose PPI use warranted in upper GI symptoms?  // PharmacoEconomics & Outcomes News;8/9/2008, Issue 559, p10 

    The article discusses research being done on proton pump inhibitors (PPI). It references a study by L. E. Targownik et al, published in a June 2008 issue of "Digestive Diseases and Sciences." Canadian researchers found that initial prescription of double-dose PPI did not lead to a reduction in...

  • Blood count in new onset atrial fibrillation after acute myocardial infarction -- A hypothesis generating study. Distelmaier, Klaus; Maurer, Gerald; Goliasch, Georg // Indian Journal of Medical Research;Apr2014, Vol. 139 Issue 4, p579 

    Background & objectives: Atrial fibrillation (AF) is a common complication after acute myocardial infarction (AMI) and associated with increased morbidity and mortality. Previous studies identified high white and red blood cell count as potential risk factors for new onset AF. The objective of...

  • Antibiotic Therapy After Acute Myocardial Infarction. Sexton, Sumi M. // American Family Physician;11/15/2003, Vol. 68 Issue 10, p2078 

    Discusses the study "Antibiotic Therapy After Acute Myocardial Infarction. A Prospective Randomized Study,' by R. Zahn et al, published in the March 11, 2003 issue of "Circulation."

  • PPIs and clopidogrel. Elliot, William T. // Clinical Oncology Alert;May2009 Pharmacology Watch, p2 

    The article discusses research to determine if there are clinical implications from the interaction between proton pump inhibitors (PPI) and clopidogrel. It references a study published in a 2009 issue of the "Journal of the American Medical Association." The researchers found that concomitant...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics